Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Grady Memorial Hospital
mi
from
Delaware, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Grady Memorial Hospital
mi
from
Delaware, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Fremont Memorial Hospital
mi
from
Fremont, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Fremont Memorial Hospital
mi
from
Fremont, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Kenton Oncology, Incorporated
mi
from
Kenton, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Kenton Oncology, Incorporated
mi
from
Kenton, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Fairfield Medical Center
mi
from
Lancaster, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Fairfield Medical Center
mi
from
Lancaster, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Lima Memorial Hospital
mi
from
Lima, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Lima Memorial Hospital
mi
from
Lima, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Luke's Hospital
mi
from
Maumee, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Luke's Hospital
mi
from
Maumee, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Charles Mercy Hospital
mi
from
Oregon, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Charles Mercy Hospital
mi
from
Oregon, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Toledo Clinic - Oregon
mi
from
Oregon, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Toledo Clinic - Oregon
mi
from
Oregon, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Firelands Regional Medical Center
mi
from
Sandusky, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Firelands Regional Medical Center
mi
from
Sandusky, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
North Coast Cancer Care, Incorporated
mi
from
Sandusky, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
North Coast Cancer Care, Incorporated
mi
from
Sandusky, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mercy Medical Center
mi
from
Springfield, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mercy Medical Center
mi
from
Springfield, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mercy Hospital of Tiffin
mi
from
Tiffin, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mercy Hospital of Tiffin
mi
from
Tiffin, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Toledo Hospital
mi
from
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Vincent Mercy Medical Center
mi
from
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Vincent Mercy Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Medical University of Ohio Cancer Center
mi
from
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Medical University of Ohio Cancer Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Toledo Clinic, Incorporated - Main Clinic
mi
from
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Toledo Clinic, Incorporated - Main Clinic
mi
from
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Fulton County Health Center
mi
from
Wauseon, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Fulton County Health Center
mi
from
Wauseon, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital
mi
from
Westerville, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital
mi
from
Westerville, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
AnMedical Health Cancer Center
mi
from
Anderson, SC
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
AnMedical Health Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Click here to add this to my saved trials
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
A Pilot Study to Test the Feasibility and Immunologic Impact of Sipuleucel-T (Provenge) Administered With or Without Anti-PD-1 mAb (CT-011) and Low Dose Cyclophosphamide in Men With Advanced Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  6/28/2016
Augusta University
mi
from
Augusta, GA
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
A Pilot Study to Test the Feasibility and Immunologic Impact of Sipuleucel-T (Provenge) Administered With or Without Anti-PD-1 mAb (CT-011) and Low Dose Cyclophosphamide in Men With Advanced Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 6/28/2016
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Registry and Database Lap Prostatectomy
Laparoscopic Radical Prostatectomy: A Registry and Database
Status: Enrolling
Updated:  6/28/2016
Methodist Hospital
mi
from
Indianapolis, IN
Registry and Database Lap Prostatectomy
Laparoscopic Radical Prostatectomy: A Registry and Database
Status: Enrolling
Updated: 6/28/2016
Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Lombardi Cancer Center at Georgetown University Medical Center
mi
from
Washington,
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Lombardi Cancer Center at Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Walter Reed Army Medical Center
mi
from
Washington,
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Memorial Regional Hospital Comprehensive Cancer Center
mi
from
Hollywood, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Memorial Regional Hospital Comprehensive Cancer Center
mi
from
Hollywood, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Palm Beach Cancer Institute, LLC
mi
from
West Palm Beach, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Palm Beach Cancer Institute, LLC
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials